A review of FDA approved drugs and their formulations for the treatment of breast cancer
Breast cancer is one of the most diagnosed solid cancers globally. Extensive research has
been going on for decades to meet the challenges of treating solid tumors with selective …
been going on for decades to meet the challenges of treating solid tumors with selective …
Nanomedicine-based drug-targeting in breast cancer: pharmacokinetics, clinical progress, and challenges
Breast cancer (BC) is a malignant neoplasm that begins in the breast tissue. After skin
cancer, BC is the second most common type of cancer in women. At the end of 2040, the …
cancer, BC is the second most common type of cancer in women. At the end of 2040, the …
Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer
Non-melanoma skin cancer is one of the most common malignancies reported with high
number of morbidities, demanding an advanced treatment option with superior …
number of morbidities, demanding an advanced treatment option with superior …
Exploring Nanocarriers for Boosting Entacapone Bioavailability: A Journey through System Characterization and Assessment of Toxicity and Pharmacological and 2D …
CS Machado, M Pinto, B Aguiar, S Costa… - … Applied Materials & …, 2024 - ACS Publications
Catechol-O-methyltransferase inhibitors (iCOMT), such as entacapone, have been
successfully employed to treat tremor-related symptoms of Parkinson's disease. However …
successfully employed to treat tremor-related symptoms of Parkinson's disease. However …
Redox responsive polymeric micelles of gellan gum/abietic acid for targeted delivery of ribociclib
In most breast tumors level of glutathione reductase is much higher than in healthy tissues.
In the current study, a redox-glutathione sensitive micelle based on Abietic acid-Cystamine …
In the current study, a redox-glutathione sensitive micelle based on Abietic acid-Cystamine …
Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro …
Purpose The current research investigated the development and evaluation of dual drug-
loaded nanostructure lipidic carriers (NLCs) of green tea extract and Ribociclib. Method In …
loaded nanostructure lipidic carriers (NLCs) of green tea extract and Ribociclib. Method In …
Ribociclib hybrid lipid–polymer nanoparticle preparation and characterization for cancer treatment
Ribociclib is a newly approved orally administered drug for breast cancer. This study aimed
to prepare, characterize, and evaluate hybrid lipid–polymer nanoparticles (PLNs) of …
to prepare, characterize, and evaluate hybrid lipid–polymer nanoparticles (PLNs) of …
Ribociclib-loaded ethylcellulose-based nanosponges: Formulation, physicochemical characterization, and cytotoxic potential against breast cancer
In the present study, ribociclib-loaded nanosponges (RCNs) composed of ethylcellulose and
polyvinyl alcohol were developed using an emulsion-solvent evaporation method …
polyvinyl alcohol were developed using an emulsion-solvent evaporation method …
Hyaluronic acid modified nanostructured lipid carrier for targeting delivery of kaempferol to NSCLC: Preparation, optimization, characterization, and performance …
Y Ma, J Liu, X Cui, J Hou, F Yu, J Wang, X Wang… - Molecules, 2022 - mdpi.com
Lung cancer seriously threatens the health of human beings, with non-small cell lung cancer
(NSCLC) accounting for 80%. Nowadays, the potential position of nano-delivery in treating …
(NSCLC) accounting for 80%. Nowadays, the potential position of nano-delivery in treating …
[HTML][HTML] Nanostructured lipid carriers as a drug delivery system: A comprehensive review with therapeutic applications
Recent advances in nanotechnology have enabled significant developments in health
through innovative drug delivery systems. Nanostructured lipid carriers (NLCs) have …
through innovative drug delivery systems. Nanostructured lipid carriers (NLCs) have …